{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "CSTONE PHARMA-B", "longName": "CStone Pharmaceuticals", "messageBoardId": "finmb_602087748", "market": "hk_market", "marketState": "CLOSED", "earningsTimestamp": 1678889627, "earningsTimestampStart": 1678889627, "earningsTimestampEnd": 1678889627, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.84, "epsForward": -0.23, "epsCurrentYear": -0.54, "priceEpsCurrentYear": -5.5925922, "sharesOutstanding": 1283180032, "bookValue": 0.375, "fiftyDayAverage": 3.608, "fiftyDayAverageChange": -0.58800006, "fiftyDayAverageChangePercent": -0.16297118, "twoHundredDayAverage": 4.0292, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -3.2051253, "regularMarketPrice": 3.02, "regularMarketChange": -0.099999905, "regularMarketTime": 1683878916, "regularMarketDayHigh": 3.14, "regularMarketDayRange": "3.01 - 3.14", "regularMarketDayLow": 3.01, "regularMarketVolume": 1551500, "regularMarketPreviousClose": 3.12, "bid": 3.02, "ask": 3.03, "bidSize": 0, "askSize": 0, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 3.09, "averageDailyVolume3Month": 3290498, "averageDailyVolume10Day": 1607583, "fiftyTwoWeekLowChange": 0.06999993, "fiftyTwoWeekLowChangePercent": 0.02372879, "fiftyTwoWeekRange": "2.95 - 6.22", "fiftyTwoWeekHighChange": -3.1999998, "fiftyTwoWeekHighChangePercent": -0.51446944, "fiftyTwoWeekLow": 2.95, "fiftyTwoWeekHigh": 6.22, "twoHundredDayAverageChange": -1.0092001, "twoHundredDayAverageChangePercent": -0.25047156, "marketCap": 3875203584, "forwardPE": -13.130434, "priceToBook": 8.053333, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.2 - Buy", "firstTradeDateMilliseconds": 1551144600000, "priceHint": 3, "symbol": "2616.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "C1 Building", "address2": "218 Xinghu Street North Block Suzhou Industrial Park", "city": "Suzhou", "zip": "215123", "country": "China", "phone": "86 512 8718 6550", "website": "https://www.cstonepharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of patients with hepatocellular carcinoma; and Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor to treat adults with relapsed or refractory acute myeloid leukemia with an IDH1 mutation. Its products also comprise CS1002, CS2006, CS3005, CS2007, CS2008, CS6001, and CS500 for solid tumors; and CS5001 for solid tumors and hematologic malignancies. The company was incorporated in 2015 and is headquartered in Suzhou, China.", "fullTimeEmployees": 476, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jianxin  Yang M.D., Ph.D.", "age": 58, "title": "CEO, Sr. VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 367253, "fmt": "367.25k", "longFmt": "367,253"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jun  Cheng", "age": 42, "title": "VP of Fin.", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ngai Chiu  Tse M.D., Ph.D.", "age": 55, "title": "Sr. VP & Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael J.  Choi M.B.A.", "age": 47, "title": "Chief Commercial Officer & Chief Strategy Officer", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. -  Zhou M.D.", "age": 41, "title": "GM of Greater China & Head of Commercial", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yin Kwan  Ho", "age": 44, "title": "Joint Company Sec.", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Weicong  Ni", "title": "Joint Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}